Ke Liu
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 04, 2025
N4BP3 promotes ovarian cancer progression and paclitaxel resistance by activating the Wnt/β-catenin signaling through interaction with XPO1.
Journal: Experimental cell research
Published: May 12, 2025
ICBP90, an epigenetic regulator, induces DKK3 promoter methylation, promotes glioma progression, and reduces sensitivity to cis-platinum.
Journal: Experimental cell research
Published: October 25, 2023
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Journal: JAMA network open
Published: May 17, 2023
Identification of low-dose radiation-induced exosomal circ-METRN and miR-4709-3p/GRB14/PDGFRα pathway as a key regulatory mechanism in Glioblastoma progression and radioresistance: Functional validation and clinical theranostic significance.
Journal: International journal of biological sciences
Published: December 18, 2020
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China.
Journal: Radiation oncology (London, England)
Published: June 15, 2020
S-1-Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial.
Journal: Frontiers in oncology
Published: May 11, 2020
FOXC1 silencing inhibits the epithelial‑to‑mesenchymal transition of glioma cells: Involvement of β‑catenin signaling.
Journal: Molecular medicine reports
Published: March 14, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026